Shiva-1

General Information


DRACP ID  DRACP01076

Peptide Name   Shiva-1

Sequence  MPRWRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVG

Sequence Length  38

UniProt ID  Not available

PubChem CID  Not available

Origin  Magainin

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
K562 Blast phase chronic myelogenous leukemia, BCR-ABL1 positive; Chronic myeloid leukemia Leukemia IC50=28.7 µM MTT assay 96 h 1
BTS-30 Breast Cancer Carcinoma IC50=56 µM MTT assay 96 h 1
HRT-18 Colon adenocarcinoma Carcinoma IC50=49.3 µM MTT assay 96 h 1
DLD-1 Colon adenocarcinoma Carcinoma IC50>100 µM MTT assay 96 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01076

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C189H322N64O45S

Absent amino acids  CEHNSTY

Common amino acids  R

Mass  490327

Pl  12.63

Basic residues  9

Acidic residues  2

Hydrophobic residues  17

Net charge  7

Boman Index  -7609

Hydrophobicity  -9.74

Aliphatic Index  107.89

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  148.65

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 7849420

Title  Preliminary experimental anticancer activity of cecropins

Doi Not available

Year  1994

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.